Clinical impact of lamivudine resistance in chronic hepatitis B

被引:21
作者
Honkoop, P [1 ]
de Man, RA
Niesters, HGM
Schalm, SW
机构
[1] Erasme Univ Hosp, Dept Hepatogastroenterol, Rotterdam, Netherlands
[2] Erasme Univ Hosp, Dept Virol, Rotterdam, Netherlands
关键词
D O I
10.1016/S0168-8278(98)80075-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:510 / 511
页数:2
相关论文
共 5 条
[1]   Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].
Bartholomew, MM ;
Jansen, RW ;
Jeffers, LJ ;
Reddy, KR ;
Johnson, LC ;
Bunzendahl, H ;
Condreay, LD ;
Tzakis, AG ;
Schiff, ER ;
Brown, NA .
LANCET, 1997, 349 (9044) :20-22
[2]  
DEMAN RA, 1998, IN PRESS J HEPATOL
[3]   Lamivudine resistance in immunocompetent chronic hepatitis B - Incidence and patterns [J].
Honkoop, P ;
Niesters, HGM ;
deMan, RAM ;
Osterhaus, ADME ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 1997, 26 (06) :1393-1395
[4]  
LEUNG NWY, 1997, HEPATOLOGY S, V26, P357
[5]   Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment [J].
Niesters, HGM ;
Honkoop, P ;
Haagsma, EB ;
de Man, RA ;
Schalm, SW ;
Osterhaus, ADME .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1382-1385